Article info

Concise report
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
  1. Correspondence to Joel M Kremer, Center for Rheumatology, Albany Medical College, 1367 Washington Ave, Albany, NY 12206, USA; jkremer{at}joint-docs.com
View Full Text

Citation

Kremer JM, Russell AS, Emery P, et al
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial

Publication history

  • Accepted June 11, 2011
  • First published September 5, 2011.
Online issue publication 
September 05, 2011
  • Web Only Data

    Files in this Data Supplement:

  • Web Only Data

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.